title: Epirubicin in a breast cancer patient with Gilbert's syndrome: apparent lack of major pharmacokinetic alterations.
authors.forename: M
authors.initials: M
authors.lastname: Riggi
authors.forename: I
authors.initials: I
authors.lastname: Poggesi
authors.forename: M B
authors.initials: MB
authors.lastname: Regazzi
authors.forename: S
authors.initials: S
authors.lastname: Grasso
authors.forename: A
authors.initials: A
authors.lastname: Fittipaldo
authors.forename: R J
authors.initials: RJ
authors.lastname: Seematter
mesh_terms: D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000493:pharmacokinetics*; D019540:Area Under Curve; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D015251:Epirubicin / Q000008:administration & dosage / Q000493:pharmacokinetics*; D005260:Female; D005500:Follow-Up Studies; D005878:Gilbert Disease / Q000150:complications*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D016896:Treatment Outcome
chemical_list: D000903:Antibiotics, Antineoplastic; D015251:Epirubicin